By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Immune Pharmaceuticals, Inc. 

150 Broadway
Suite 1801
New York  New York  10038  U.S.A.
Phone: 646-937-1941 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Immune Pharmaceuticals, Inc. Signs License & Research Agreement For AmiKet Nano 6/29/2015 6:34:27 AM
Immune Pharmaceuticals, Inc. Initiates Phase II Clinical Trials With Bertilimumab In Ulcerative Colitis And Bullous Pemphigoid 6/26/2015 6:26:37 AM
Immune Pharmaceuticals, Inc. Expands Immuno-Dermatology Development Portfolio With Topical Nano-Formulated Cyclosporine A 6/10/2015 6:50:41 AM
Immune Pharmaceuticals, Inc. To Present At Goldman, Sachs & Co. Immuno-Oncology Business Development (BD&L) And Investment Forum In Chicago And At Marcum Conference In New York 5/28/2015 7:41:20 AM
Immune Pharmaceuticals, Inc. Reports First Quarter 2015 Financial Results; Bertilimumab Phase II Trials Ready To Enroll Patients 5/18/2015 10:27:21 AM
Immune Pharmaceuticals, Inc. And STC Biologics, Inc Announce Strategic Partnership To Accelerate The Development Of NanomAbs 5/4/2015 6:35:16 AM
Immune Pharmaceuticals, Inc. Reports Fourth Quarter And Full Year 2014 Financial Results 4/16/2015 7:46:35 AM
Immune Pharmaceuticals, Inc. To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 3/31/2015 10:15:31 AM
Immune Pharmaceuticals, Inc. To Develop Novel Topical Nanoparticle Formulation Of Amiket 3/17/2015 10:53:50 AM
Immune Pharmaceuticals, Inc. To Present At The Roth Conference 3/3/2015 10:27:22 AM
1234567
//-->